Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
01 1Pharmaceutical Works POLPHARMA
02 1Dr.Reddy's Laboratories Limited
03 1Interquim, S.A.
04 1Cohance Lifesciences Limited
05 1Medichem Manufacturing (Malta) Ltd.
06 1Medichem S.A.
07 1Neuland Laboratories Limited
08 1USV Private Limited
09 1Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.)
10 1Assia Chemical Industries Ltd - Teva Tech Site
11 1Aurobindo Pharma Limited
12 1Bajaj healthcare Ltd
13 1Bayer AG
14 1Biocon Limited
15 1Cipla Ltd.
16 1Glenmark Life Sciences Limited
17 1HETERO DRUGS LIMITED
18 1HIKAL LIMITED
19 1Indoco Remedies Limited
20 1Jubilant Pharmova Limited
21 1Lee Pharma Ltd.
22 1MSN Laboratories Private Limited
23 1Mylan Laboratories Limited
24 1Nantong Chanyoo Pharmatech Co., Ltd
25 1Optimus Drugs Private Limited
26 2Quimica Sintetica S.A.
27 1SYNAPTICS LABS PRIVATE LIMITED
28 1Srini Pharmaceuticals Private Limited
29 1Symed Labs Limited
30 1Teva Czech Industries s.r.o
31 1Unichem Laboratories Limited, India
32 1Uquifa Mexico, S.A. de C.V.
33 1Zhejiang Huahai Pharmaceutical Co., Ltd.
34 1Zhejiang Supor Pharmaceuticals Co., Ltd
01 7RIVAROXABAN
02 24Rivaroxaban
03 1Rivaroxaban Microfine
04 1Rivaroxan
05 2rivaroxaban
01 3China
02 1Germany
03 20India
04 2Israel
05 1Poland
06 6Spain
07 1U.S.A
08 1Blank
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
NDC Package Code : 12658-0516
Start Marketing Date : 2011-07-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-966
Start Marketing Date : 2014-03-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
NDC Package Code : 64552-4049
Start Marketing Date : 2011-07-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 76072-1008
Start Marketing Date : 2017-06-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
NDC Package Code : 16436-0109
Start Marketing Date : 2011-12-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58032-2029
Start Marketing Date : 2017-12-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62147-0287
Start Marketing Date : 2024-12-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
NDC Package Code : 53296-0109
Start Marketing Date : 2011-12-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12527-0580
Start Marketing Date : 2014-05-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14445-024
Start Marketing Date : 2024-03-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Rivaroxaban manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rivaroxaban, including repackagers and relabelers. The FDA regulates Rivaroxaban manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rivaroxaban API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rivaroxaban manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rivaroxaban supplier is an individual or a company that provides Rivaroxaban active pharmaceutical ingredient (API) or Rivaroxaban finished formulations upon request. The Rivaroxaban suppliers may include Rivaroxaban API manufacturers, exporters, distributors and traders.
click here to find a list of Rivaroxaban suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rivaroxaban as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rivaroxaban API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rivaroxaban as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rivaroxaban and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rivaroxaban NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rivaroxaban suppliers with NDC on PharmaCompass.
We have 32 companies offering Rivaroxaban
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?